Atlas Trials

Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China

Clinical trial NCT01812096 · UNKNOWN

Trial details

NCT number
NCT01812096
Sponsor
The First Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma Proved by Laboratory Tests
Start date
2014-05-01
Primary completion
2016-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.